![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/245 | (2006.01) |
C07K 14/005 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
C07K 16/088 | (2013.01) | ||
C12N 7/00 | (2006.01) | ||
C12N 7/00 | (2013.01) | ||
C07K 14/005 | (2006.01) | ||
C12N2710/16122 | (2013.01) | ||
A61K 39/12 | (2006.01) | ||
C12N2710/16134 | (2013.01) | ||
C07K 16/08 | (2006.01) | ||
A61K 39/12 | (2013.01) | ||
A61P 31/22 | (2006.01) | ||
A61K 39/245 | (2013.01) | ||
A61P 37/04 | (2006.01) | ||
A61P 31/22 | (2018.01) | ||
A61P 37/04 | (2018.01) |
(11) | Number of the document | 3031469 |
(13) | Kind of document | T |
(96) | European patent application number | 16152758.5 |
Date of filing the European patent application | 2007-06-06 | |
(97) | Date of publication of the European application | 2016-06-15 |
(45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
811689 P | 2006-06-07 | US | |
902544 P | 2007-02-20 | US |
(72) |
SHENK, Thomas , US
WANG, Dai , US
|
(73) |
The Trustees Of Princeton University ,
New South Building
4th Floor
P.O. Box 36, Princeton, New Jersey 08544,
US
|
(54) | CYTOMEGALOVIRUS SURFACE PROTEIN COMPLEX FOR USE IN VACCINES AND AS A DRUG TARGET |
CYTOMEGALOVIRUS SURFACE PROTEIN COMPLEX FOR USE IN VACCINES AND AS A DRUG TARGET |